| P2093 | author name string | G Liu | |
| | H Yang | |
| | X Wang | |
| | Z Zhang | |
| | J Wang | |
| | Y Lu | |
| | X Chen | |
| | K Shao | |
| P2860 | cites work | Future of Medicare immunosuppressive drug coverage for kidney transplant recipients in the United States | Q26866026 |
| | Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation | Q29620223 |
| | The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic-uraemic syndrome | Q33498349 |
| | Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy | Q33917765 |
| | Type 1 T Helper Cells Induce the Accumulation of Myeloid-Derived Suppressor Cells in the Inflamed Tgfb1 Knockout Mouse Liver | Q34163882 |
| | Expressive dysphasia possibly related to FK506 in two liver transplant recipients | Q34252019 |
| | Tacrolimus (FK506) versus cyclosporine microemulsion (neoral) as maintenance immunosuppression therapy in kidney transplant recipients | Q34457995 |
| | Opposing roles for calcineurin and ATF3 in squamous skin cancer | Q34632548 |
| | Review: metabolism of immunosuppressant drugs | Q34706286 |
| | The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation | Q34846497 |
| | Dendritic cell SIRT1-HIF1α axis programs the differentiation of CD4+ T cells through IL-12 and TGF-β1. | Q35156962 |
| | Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome | Q36029868 |
| | Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants | Q36355038 |
| | Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo | Q36361067 |
| | The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms | Q37091570 |
| | The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. | Q37319760 |
| | Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells | Q39109664 |
| | Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine. The US Multicenter FK506 Liver Study Group | Q40630682 |
| | IL-17A produced by neutrophils protects against pneumonic plague through orchestrating IFN-γ-activated macrophage programming | Q41391001 |
| | CsA, FK506, corticosteroids and rapamycin inhibit TNF alpha production by cultured PTEC. | Q41535868 |
| | Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation | Q41689014 |
| | Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients | Q42171648 |
| | Induction therapy in pediatric kidney transplant recipients discharged with a triple drug immunosuppressive regimen | Q43061426 |
| | A retrospective analysis of the safety and efficacy of low dose tacrolimus (FK506) for living donor liver transplant recipients | Q43077770 |
| | Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients | Q43241173 |
| | Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience | Q43752479 |
| | A surgical technique for experimental free skin grafting in mice | Q44149995 |
| | Modulation of the electrophoretic mobility of the linker for activation of T cells (LAT) by the calcineurin inhibitors CsA and FK506: LAT is a potential substrate for PKC and calcineurin signaling pathways. | Q44195095 |
| | Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. | Q44250760 |
| | Tacrolimus (FK506)-induced mutism after liver transplant | Q44406547 |
| | Silibinin protects mice from T cell-dependent liver injury | Q44555689 |
| | Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients | Q44651850 |
| | The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands. | Q45957723 |
| | Immunosuppression with either cyclosporine a or FK506 supports survival of transplanted fibroblasts and promotes growth of host axons into the transplant after spinal cord injury | Q46817733 |
| | Psychodynamic evaluation of kidney transplant patients enrolled in a new immunosuppressive drug trial. | Q51068508 |
| | The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. | Q53568218 |
| | Phosphatase Wip1 negatively regulates neutrophil migration and inflammation. | Q54386224 |
| | Different effects of CsA and FK506 on aquaporin-2 abundance in rat primary cultured collecting duct cells. | Q54573079 |
| | THE ANTINEOPLASTIC DRUG PACLITAXEL HAS IMMUNOSUPPRESSIVE PROPERTIES THAT CAN EFFECTIVELY PROMOTE ALLOGRAFT SURVIVAL IN A RAT HEART TRANSPLANT MODEL1 | Q57083105 |
| P433 | issue | 2 | |
| P304 | page(s) | 119-127 | |
| P577 | publication date | 2015-11-02 | |
| P1433 | published in | Scandinavian Journal of Immunology | Q15762682 |
| P1476 | title | Different Effects of Tacrolimus on Innate and Adaptive Immune Cells in the Allograft Transplantation | |
| P478 | volume | 83 | |